Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

2.

SRE elements are binding sites for the fusion protein EWS-FLI-1.

Magnaghi-Jaulin L, Masutani H, Robin P, Lipinski M, Harel-Bellan A.

Nucleic Acids Res. 1996 Mar 15;24(6):1052-8.

3.

Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.

Lessnick SL, Braun BS, Denny CT, May WA.

Oncogene. 1995 Feb 2;10(3):423-31.

PMID:
7845667
5.
6.

Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.

Morohoshi F, Ootsuka Y, Arai K, Ichikawa H, Mitani S, Munakata N, Ohki M.

Gene. 1998 Oct 23;221(2):191-8.

PMID:
9795213
7.

EWS/Fli-1 chimeric protein is a transcriptional activator.

Ohno T, Rao VN, Reddy ES.

Cancer Res. 1993 Dec 15;53(24):5859-63.

PMID:
7503813
8.

Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein.

Chansky HA, Hu M, Hickstein DD, Yang L.

Cancer Res. 2001 May 1;61(9):3586-90.

9.

Oncogenic EWS-Fli1 interacts with hsRPB7, a subunit of human RNA polymerase II.

Petermann R, Mossier BM, Aryee DN, Khazak V, Golemis EA, Kovar H.

Oncogene. 1998 Aug 6;17(5):603-10.

11.
12.
13.

DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.

Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, Roussel M, Thomas G, Ghysdael J.

Mol Cell Biol. 1994 May;14(5):3230-41.

15.

Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis.

Braun BS, Frieden R, Lessnick SL, May WA, Denny CT.

Mol Cell Biol. 1995 Aug;15(8):4623-30.

16.

Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.

Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, Sorensen PH, Thiele CJ, Kim SJ.

Nat Genet. 1999 Oct;23(2):222-7. Erratum in: Nat Genet 1999 Dec;23(4):481.

PMID:
10508522
18.

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.

May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, Lunsford LB, Hromas R, Denny CT.

Mol Cell Biol. 1993 Dec;13(12):7393-8.

19.

The splicing factor U1C represses EWS/FLI-mediated transactivation.

Knoop LL, Baker SJ.

J Biol Chem. 2000 Aug 11;275(32):24865-71.

20.

Supplemental Content

Support Center